STANDARD BIOTOOLS INC. - COMMON STOCK

Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024

17 7 2024 05:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers

28 5 2024 13:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

22 5 2024 13:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

20 5 2024 05:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools Reports First Quarter 2024 Financial Results

08 5 2024 13:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

25 4 2024 05:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

25 4 2024 05:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

08 4 2024 05:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research

03 4 2024 13:01:13 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

18 3 2024 05:12:23 提供 Nasdaq GlobeNewswire

Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results

28 2 2024 13:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing

26 2 2024 05:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

22 2 2024 13:05:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

14 2 2024 05:30:00 提供 Nasdaq GlobeNewswire

Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine

07 2 2024 05:30:35 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue

08 1 2024 05:30:32 提供 Nasdaq GlobeNewswire

Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools

05 1 2024 05:46:55 提供 Nasdaq GlobeNewswire

Standard BioTools Stockholders Approve Merger with SomaLogic

04 1 2024 19:23:06 提供 Nasdaq GlobeNewswire

Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

29 12 2023 14:04:12 提供 Nasdaq GlobeNewswire

ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

22 12 2023 15:57:33 提供 Nasdaq GlobeNewswire